PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+8.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.74B
AUM Growth
+$3.74B
(-2.1%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
148
New
23
Increased
20
Reduced
26
Closed
34
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$74.1M |
| 2 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$41.6M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$33.9M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$24.2M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$20.3M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$65.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$57.5M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$56.8M |
| 4 |
Humana
HUM
|
$38.3M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$35.2M |
Sector Composition
| 1 | Healthcare | 90.77% |
| 2 | Financials | 0.17% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Industrials | 0.03% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECYT
26
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $43.4M | 1.16% |
2,441,700
+520,000
| +27% | +$9.24M |
|
27
Aldeyra Therapeutics
ALDX
$350M
| $42.6M | 1.14% |
3,085,458
| – | – |
|
28
argenx
ARGX
$44.2B
| $42.5M | 1.14% |
560,941
+31,381
| +6% | +$2.38M |
|
29
Intuitive Surgical
ISRG
$158B
| $41.6M | 1.11% |
217,500
-82,500
| -28% | -$15.8M |
|
30
ADMA Biologics
ADMA
$4.03B
| $40.5M | 1.08% |
6,521,102
| – | – |
|
|
BHVN
31
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $37.2M | 1% |
990,943
-1,752,704
| -64% | -$65.8M |
|
32
Regenxbio
RGNX
$498M
| $35.5M | 0.95% |
470,672
-396,434
| -46% | -$29.9M |
|
33
uniQure
QURE
$954M
| $35.4M | 0.95% |
972,831
-471,797
| -33% | -$17.2M |
|
|
VRAY
34
DELISTED
ViewRay, Inc.
VRAY
| $34.6M | 0.93% |
3,700,000
+3,625,000
| +4,833% | +$33.9M |
|
|
NEPT
35
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $34.5M | 0.92% |
6,351
+227
| +4% | +$1.23M |
|
36
Xencor
XNCR
$594M
| $32.3M | 0.86% |
828,095
-240,000
| -22% | -$9.35M |
|
|
NVTA
37
DELISTED
Invitae Corporation
NVTA
| $31.1M | 0.83% |
1,861,100
-160,000
| -8% | -$2.68M |
|
|
CBAY
38
DELISTED
Cymabay Therapeutics
CBAY
| $30.4M | 0.81% |
2,742,821
| – | – |
|
|
VBIV
39
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $23.4M | 0.63% |
322,195
| – | – |
|
40
Akebia Therapeutics
AKBA
$827M
| $21.6M | 0.58% |
2,449,521
+234,121
| +11% | +$2.07M |
|
41
Aquestive Therapeutics
AQST
$478M
| $20.1M | 0.54% |
+1,150,000
| New | +$20.1M |
|
42
Rhythm Pharmaceuticals
RYTM
$6.75B
| $19.4M | 0.52% |
664,186
-136,500
| -17% | -$3.98M |
|
|
FOMX
43
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $17.8M | 0.48% |
3,107,424
+1,990,100
| +178% | +$11.4M |
|
44
Zymeworks
ZYME
$1.07B
| $16.9M | 0.45% |
1,123,890
| – | – |
|
45
iRhythm Technologies
IRTC
$5.67B
| $16M | 0.43% |
168,939
-139,067
| -45% | -$13.2M |
|
46
Establishment Labs
ESTA
$1.11B
| $15.3M | 0.41% |
+635,000
| New | +$15.3M |
|
47
ProQR Therapeutics
PRQR
$256M
| $14.7M | 0.39% |
+761,000
| New | +$14.7M |
|
|
MOTS
48
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $14.3M | 0.38% |
9,368
| – | – |
|
49
LivaNova
LIVN
$3.09B
| $13.8M | 0.37% |
+111,000
| New | +$13.8M |
|
50
Synlogic
SYBX
$17.4M
| $13.4M | 0.36% |
62,857
| – | – |
|